您的购物车当前为空
BzATP triethylammonium salt 是一种 P2X 受体激动剂,对 P2X1、P2X2、P2X3、P2X2/3、P2X4 和 P2X7 均有效 (pEC50=8.74/5.26/7.10/7.50/6.19/6.31/5.33)。BzATP triethylammonium salt 可以诱导细胞死亡并减少突触传递。


为众多的药物研发团队赋能,
让新药发现更简单!
BzATP triethylammonium salt 是一种 P2X 受体激动剂,对 P2X1、P2X2、P2X3、P2X2/3、P2X4 和 P2X7 均有效 (pEC50=8.74/5.26/7.10/7.50/6.19/6.31/5.33)。BzATP triethylammonium salt 可以诱导细胞死亡并减少突触传递。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 410 | In stock | |
| 5 mg | ¥ 977 | In stock | |
| 10 mg | ¥ 1,570 | In stock | |
| 25 mg | ¥ 3,230 | In stock | |
| 50 mg | ¥ 3,990 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,870 | In stock |
BzATP triethylammonium salt 相关产品
| 产品描述 | BzATP triethylammonium salt is a P2X receptor agonist that is effective against P2X1, P2X2, P2X3, P2X2/3, P2X4, and P2X7 (pEC50=8.74/5.26/7.10/7.50/6.19/6.31/5.33). BzATP triethylammonium salt induces cell death and reduces synaptic transmission. |
| 靶点活性 | P2X7 (Rat):3.6 μM, P2X1:8.74 (pEC50), P2X4:6.31 (pEC50), P2X2:5.26 (pEC50), P2X3:7.1 (pEC50) |
| 体外活性 | 方法:胶质瘤细胞系 U87 和 U251 用 BzATP triethylammonium salt (5-1000 µM) 处理 2-72 h,使用 MTT assay 检测细胞增殖。 |
| 体内活性 | 方法:为研究对全身能量代谢的影响,将 BzATP triethylammonium salt (1 mg/kg) 腹腔注射给 C57BL/6J 小鼠,每天一次,持续七天。 |
| 分子量 | 816.59 |
| 分子式 | C30H39N6O15P3 |
| CAS No. | 112898-15-4 |
| Smiles | O[C@H]1[C@@H](O[C@@H]([C@H]1OC(C2=CC=C(C=C2)C(C3=CC=CC=C3)=O)=O)COP(OP(OP(O)(O)=O)(O)=O)(O)=O)N4C=NC5=C4N=CN=C5N.CCN(CC)CC |
| 密度 | no data available |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | store at low temperature,keep away from moisture,store under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | H2O: 50.00 mg/mL (61.23 mM), Sonication is recommended. DMSO: 50.00 mg/mL (61.23 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (2.45 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
H2O/DMSO
| |||||||||||||||||||||||||||||||
评论内容